Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Using human genetics to understand the disease impacts of testosterone in men and women

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Recurrent MET fusion genes represent a drug target in pediatric glioblastoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A Polygenic Risk Score Suggests Shared Genetic Architecture of Voice Break With Early Markers of Pubertal Onset in Boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The External Genitalia Score (EGS): A European multicenter validation study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Large-scale GWAS reveals insights into the genetic architecture of same-sex sexual behavior

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Factors affecting timing and progression of male puberty

    Publikation: Bog/antologi/afhandling/rapportPh.d.-afhandlingForskning

  • Endometrial Cancer Association Consortium
Vis graf over relationer

Testosterone supplementation is commonly used for its effects on sexual function, bone health and body composition, yet its effects on disease outcomes are unknown. To better understand this, we identified genetic determinants of testosterone levels and related sex hormone traits in 425,097 UK Biobank study participants. Using 2,571 genome-wide significant associations, we demonstrate that the genetic determinants of testosterone levels are substantially different between sexes and that genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men. For example, a genetically determined 1 s.d. higher testosterone increases the risks of type 2 diabetes (odds ratio (OR) = 1.37 (95% confidence interval (95% CI): 1.22-1.53)) and polycystic ovary syndrome (OR = 1.51 (95% CI: 1.33-1.72)) in women, but reduces type 2 diabetes risk in men (OR = 0.86 (95% CI: 0.76-0.98)). We also show adverse effects of higher testosterone on breast and endometrial cancers in women and prostate cancer in men. Our findings provide insights into the disease impacts of testosterone and highlight the importance of sex-specific genetic analyses.

OriginalsprogEngelsk
TidsskriftNature Medicine
Vol/bind26
Udgave nummer2
Sider (fra-til)252-258
Antal sider7
ISSN1078-8956
DOI
StatusUdgivet - feb. 2020

ID: 59308573